In Molecular Pursuit of Bone Metastasis by Fluciclovine PET
Diagnosing bone metastases with traditional anatomic modalities, such as MRI and CT, is limited by sensitivity, and conventional bone radiotracers are only indirect markers of cancer activity. Fortunately, molecular imaging is uniquely capable of providing radiotracers such as fluciclovine and radiolabeled choline, that actually target tumors in the bone. The merits of research in imaging osseous metastases in animal models using these radiotracers and the implications for future clinical translation are discussed.
Source: Theranostics - Category: Molecular Biology Authors: Liza Lindenberg Tags: Editorial Source Type: research
More News: Cancer | Cancer & Oncology